CompaniesInterMune

InterMune

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (23)

Total Trials

23

As Lead Sponsor

15

As Collaborator

8

Total Enrollment

3,816

By Phase

PHASE2: 10PHASE4: 2PHASE3: 6PHASE1/PHASE2: 3

By Status

COMPLETED: 15TERMINATED: 6UNKNOWN: 2

Clinical Trials Pipeline23 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

Today

Hover over trial bars to see details

Recent Trials

NCT02176707Collaborator

Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis

250 participants

Started: Jun 30, 2014 · Completed: Feb 28, 2017

NCT00753467Collaborator

A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B

30 participants

Started: Sep 30, 2008 · Completed: Aug 31, 2009

NCT00786643Collaborator

Study of Gamma Interfereon in Metastatic Colorectal Carcinoma

PHASE2Completed

48 participants

Started: Feb 28, 2006 · Completed: Mar 31, 2010

NCT00266318Collaborator

Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy

PHASE4Completed

40 participants

Started: Dec 31, 2005 · Completed: May 31, 2007

NCT00207402Collaborator

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

PHASE4Completed

34 participants

Started: Oct 31, 2005 · Completed: Jul 31, 2010

View all 23 trials →

Funding History (20)

8-K

Oct 2, 2014

8-K

Sep 29, 2014

8-K

Sep 5, 2014

8-K

Aug 25, 2014

8-K

Aug 6, 2014

8-K

Jul 17, 2014

8-K

Jul 3, 2014

8-K

Jul 2, 2014

8-K

Jun 25, 2014

8-K

Jun 4, 2014

InterMune | Biotech Hunter | Biotech Hunter